Pharmacology and clinical evaluation of the anti-angiogenesis agent ramucirumabMA Ying, WANG Ting, MA Yi-ming, LIN Bi-rong2339-2343
Application of data comparison analysis in lot releaseMA Xiao, ZHANG Hua-jie, HOU Wen-ting, PAN Hai-long, TAN Ya-jun2349-2350,2365
Advances in approval and supervision of the similar biotherapeutic productGUO Wei, WANG Lan, GAO Kai2351-2355
Current approach in scientific and regulatory requirements of generic low-molecular-weight heparinHUA Wei-li, WANG Tao2356-2359
Development of standardized methods for quality control of humanized monoclonal antibody HcHAb18 and structure confirmation of its reference substance for physicochemical analysis范文红, 陶磊, 李响, 丁有学, 韩春梅, 裴德宁, 郭莹, 杨靖青, 毕华2360-2365
Establishment and validation of nimotuzumab identification method with capillary zone electrophoresis郭玮, 王兰, 王文波, 张峰, 于传飞, 李萌, 刘春雨, 高凯2366-2369,2381
Development and application of capillary zone electrophoresis for purity analysis of enterovirus type 71 inactivated vaccineWU Yun-yi, GUO Hui-jie, MA Shu-hua, CHEN Lei, WEN Zhi-heng, LU Wei-wei, LI Xiu-ling2370-2376,2405
Validation and its application of an ELISA method for the detection of anti-drug antibody against recombinant potent anti-tumor and anti-virus protein in patient sera贾敏, 王立清, 段瑾, 盛艾娟, 丁淑芹, 陈曦, 郑凤敏, 王美霞, 吕秋军2377-2381